PROMEDICON 2027 unites medicinal chemists, drug discovery scientists, and pharmaceutical innovators from academia, industry, and government — converging in Kyoto, Japan's historic cradle of science and culture.
Medicinal chemistry lies at the very heart of how new medicines are discovered and developed. It blends creativity with rigorous science, integrating chemistry, biology, and pharmacology to design molecules that treat disease, relieve suffering, and improve lives.
PROMEDICON 2027 serves as a global platform connecting discovery science with real-world therapeutic impact — held at Kyoto University, Japan, a global leader in next-generation drug innovation.
PROMEDICON 2027 spans the full spectrum of contemporary medicinal chemistry and pharmaceutical science.
Harnessing AI, quantum computing, and digital twins to transform molecular design at unprecedented scale.
mRNA platforms, antibody-drug conjugates, biologics, and microbiome-based therapeutic innovations.
PROTACs, targeted protein degradation, polypharmacology, and advanced synthesis strategies.
Immuno-oncology, neurodegeneration, rare disease drug discovery, and personalized therapeutics.
Nanomedicine, blood-brain barrier strategies, PK/PD & ADME, and lab-to-market translation.
Radioligand therapy, molecular imaging, and the integration of diagnosis with therapy.
Green and circular chemistry principles, natural products, and eco-friendly pharmaceutical processes.
Autonomous laboratories, high-throughput experimentation, robotics, and AI-driven process optimization.
A comprehensive agenda spanning AI-driven discovery, translational medicine, and sustainable pharmaceutical futures.
FOCUS: AI · Data Science · Molecular Design · Chemical Biology
FOCUS: Biologics · Precision Medicine · Drug Delivery · Theranostics
FOCUS: Green Chemistry · Automation · Regulation · Innovation Ecosystems
PROMEDICON 2027 welcomes the entire drug discovery ecosystem — from bench to boardroom.
Professors, PhD scholars, and computational scientists in medicinal chemistry, chemical biology, and pharmaceutical sciences.
R&D leaders and clinical researchers advancing small molecules, biologics, and next-generation therapeutics.
ML researchers, data scientists, and automation engineers applying machine learning to drug discovery.
Oncologists, neurologists, and clinical investigators driving precision medicine from lab to clinic.
Experts in gene therapy, mRNA platforms, immunotherapy, and targeted protein degradation.
Specialists in sustainable chemistry, catalysis, and scalable pharmaceutical manufacturing.
Specialists in regulatory science, ethics, and global drug approval navigating complex compliance landscapes.
Entrepreneurs, venture capitalists, and innovation leaders driving the next wave of biotech breakthroughs.
MSc and PhD candidates seeking mentorship, collaboration, and career-defining scientific opportunities.
One of Asia's premier research universities, Kyoto University is a fitting host for a conference at the frontier of molecular science. The historic city of Kyoto provides an unparalleled backdrop — where centuries of culture meet cutting-edge innovation.
Kyoto, Japan · March 2027
Secure your place at the premier global gathering of medicinal chemistry and drug discovery innovation. Early-bird rates available for a limited time.